PER 0.00% 8.0¢ percheron therapeutics limited

Ann: Positive effects with ATL1102 on MS Black Hole lesions, page-18

  1. 3,224 Posts.
    lightbulb Created with Sketch. 259
    ITSA you are somehow late to welcome Prof. Barkohof in the team you should have done minimum
    3 years ago since together with Prof. Limroth and your beloved guru Diamond they wrote an article
    reporting ATL1102 data including MRI data sometime in November 2014.
    Also when you write:
    "ANP Board have always stated that if there is any material change in their announcements they will announce it..."
    Well the IND process was supposed to be delivered in May and allegedly hasn't happened yet. Do you
    call material change or due to such the usual professional behaviour of management we should assume that
    now the documentation is in the proper FDA department ? Also the words normally used by Diamond in his
    various announcements such "is expected" "should" "potentially be" aren't to be considered vague terms
    but strong reality and the only reason ANP does not follow up is because there is no need to doubt their
    precision and transparency in the announcements' content ?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.